|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
TreatmentMultidisciplinary Clinics The faculty of the Siteman Cancer Center provide disease-specific, multi-disciplinary care utilizing a broad array of clinical care options. Multi-disciplinary teams are developed to be specific to the disease being treated. Most oncology patients receive their outpatient care in the outpatient facility of the Siteman Cancer Center, located in the Center for Advanced Medicine on the Washington University Medical Center campus. All diagnostic and treatment-related care is provided in a single location within this building. For the convenience of patients living within the St. Louis metropolitan area, the Siteman Cancer Center has also established two community-based programs bearing the Siteman name, one in west St. Louis County at Barnes-Jewish West County Hospital and the second in St. Peters, Missouri. New patient appointments are coordinated to ensure that all physicians a newly diagnosed patient might need to see in order to establish an appropriate treatment plan happen within a single day, thereby minimizing the travel needs of patients and providing prompt recommendations for treatment planning. All of the following disease centers can be reached by calling 800.600.3606.
Transplant Programs The Bone Marrow and Stem Cell Transplant Program at the Siteman Cancer Center is consistently ranked as one of the top five transplant centers in the world based on volume of transplants performed each year. The program offers expertise in the treatment of pre-leukemia and acute leukemia. In addition, a high volume of patients receive treatment for multiple myeloma. The service consistently has over 40 open transplant-specific clinical trials. A comprehensive patient evaluation and treatment planning process has also been nationally recognized as a “best practice.” Since 1975, over 3,000 patients have been transplanted at the center. The annual number of transplants exceeds 260, fairly evenly divided between autologous and allogeneic transplants. Approprixmately half of the allogeneic volume is composed of patients requiring matched unrelated donor transplants. A 26-bed inpatient unit provides acute and critical care for transplant patients, and a newly established 38-bed hematologic unit provides care for patients diagnosed with leukemia or who require care for lymphoma and other blood-related cancers. Patient care is delivered in a structured, patient-focused manner. The service recently received recertification through the Foundation of Cellular Therapy (FACT) program. In addition to comprehensive clinical care, the tradition of focused translational research in the area of understanding the development of acute leukemia has been supported by a National Cancer Institute Program Project Grant (P01) titled “Genomics of Acute Myeloid Leukemia”. As a result of this grant, a large clinical and genetic tumor bank has been established to study all of the mutations associated with acute myelogenous leukemia with the intent of designing new therapeutic targets in the future. Complementary and Alternative Medicine The Siteman Cancer Center offers an array of supportive services to complement a patient’s treatment plan. Such services include a comprehensive nutritional counseling service, which provides support to inpatients and outpatients, and massage therapy. A wide variety of course offerings allow patients to learn about the benefits of exercise, relaxation, and self-expression through art as part of their cancer treatment. Cancer Prevention and ScreeningThe Siteman Cancer Center is recognized as a community leader in offering cancer risk-reduction initiatives and cancer screenings. A comprehensive community outreach program provides more than 200 community offerings and 30 continuing medical education (CME) activities to the entire geographic area, regardless of a participant’s ability to pay. Over 30,000 people participate in these structured sessions each year. In addition, the Siteman Cancer Center partners with public school systems to establish anti-smoking initiatives. Prior to the development of the Siteman Cancer Center, Barnes-Jewish Hospital’s Breast Health Center established, through the Mallinkrodt Institute of Radiology , the first mobile mammography van west of the Mississippi River. Since that time, the van has grown to serve both corporate clients and underserved communities in the metropolitan St. Louis area and the rural Missouri “bootheel” area. Both of these areas are known to have a higher incidence of breast cancer development than the general population of Missouri. In 2005, the mobile mammography program served over 8,000 women. In the fall of 2006, the screening and diagnostic mammography services for the Siteman Cancer Center was the first in the Midwest to convert to total full-field digital mammography equipment. As a result of the infrastructure established for cancer screenings, the Siteman Cancer Center was recognized by the state of Missouri and selected as one of the sites for Show-Me Healthy Missouri, which provides financial support for women being screened for cervical and breast cancer. The program was recently expanded to include support for colorectal cancer screening. The Siteman Cancer Center has always been the leading provider of services for these state-based programs. As a result of this success, legislation passed by the state mandates that women who are diagnosed through these programs be automatically covered through Missouri Medicaid, thereby relieving them from the burden of financing treatment. The Siteman Cancer Center works in close collaboration with colleagues from the Saint Louis University School of Public Health, which holds an NCI Center of Excellence in Cancer Communications Research (P50) grant. Collaborations have been established to focus patient education material development on targeted messages that might better influence health behavior changes. St. Louis remains the third-largest refugee resettlement center in the country. This has allowed the Siteman Cancer Center to gain added experience in developing culturally competent programs and services. A number of initiatives are moving forward related to cancer prevention: The Prevention and Control Research Program aims to develop, advance, and evaluate improved interventions in smoking prevention and cessation, early detection, epidemiology, cancer communication and interventions, psychosocial aspects of care, and chemoprevention. A key theme in the program (including research on interventions to prevent cancer and enhance cancer care) is dissemination to low-income and minority groups that suffer disproportionate cancer burden. The program received a Community Networks Program U01 grant in 2005 for the Program for the Elimination of Cancer Disparities (PECaD), which addresses disparities in care, outreach, education, training, and research with a particular focus on African Americans, the largest minority group in the St. Louis region. The Chemoprevention Focus Group works to identify and test improved agents that prevent the development or recurrence of cancer in people at risk. This work is based on fundamental plant science and other basic science approaches, building on unique collaborations with the renowned Missouri Botanical Garden and the Donald Danforth Plant Science Center. Experts in the basic sciences have worked to develop new chemopreventive agents for use in animal and then human trials. Support ServicesThe Siteman Cancer Center offers a wide array of support services for cancer patients and their families from initial diagnosis through survivorship. Such services include “wayfinding” navigation, in which a patient is linked with a Siteman Cancer Center volunteer who escorts them to all of their physician and laboratory visits during their first time at the center. A variety of “patient navigation” services are provided to aid patients through their treatment plan based on their diagnosis. Classes developed in response to the needs of cancer patients and their families are provided in easily accessed forums throughout the week. Structured support groups are in place for women with breast cancer, children of mothers and grandmothers with cancer, family members of bone marrow and stem cell transplant patients, women who are being treated/have been treated for gynecological cancers, and young adults with cancer. Plans are being developed to establish education and support services for caregivers of loved ones going through cancer treatment. The Siteman Cancer Center provides nutritional counseling for inpatients and outpatients, and psychosocial support services are also provided through social workers, psychologists, and psychiatry consultation. A comprehensive cancer resource center, the Barnard Health and Cancer Information Center, is also located in the same building where cancer patients come for treatment. The center provides written materials, videos, and assistance with internet searches for cancer patients and their families. The center is staffed with nurses who can provide additional information and support to patients and families, linking them to appropriate resources. It also provides wigs, breast prostheses, and bras for uninsured/underinsured women who have had mastectomies and offers arts as healing projects, including drawing classes. Supportive CarePain Service Siteman Cancer Center patients benefit from access to the Pain Management Program. Using a muti-modality approach, the Pain Management Program seeks to tailor treatment plans for acute and chronic cancer pain to the unique needs of the patient. Palliative/Supportive Service An inpatient consultation service for palliative care and an outpatient palliative care clinic were established in 2005. Patients and families benefit from the strong relationship established between this service and the primary oncology team. Home Care/Hospice Service BJC HealthCare provides comprehensive home care, supportive care, and hospice services. In the event patients reside outside the service area covered by the program, BJC Home Care and BJC Hospice coordinate referrals for patients needing services in outlying areas. Nutrition Service Registered dietitians are available to establish specific nutritional plans that are unique to patients, their disease and their treatment plan. Cooperative Group Membership
Clinical and Research EffortsAdult Oncology Program - 2006
* Total of outpatient oncology visits of 92,267 Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Location |
Washington University School of Medicine |
|
Program Director |
Alison Whelan, MD |
|
Schedule Appointments |
Adult Genetics Clinic - 314.454.6093 |
.
Community and Physician Awareness |
Information about the Siteman Cancer Center Cancer Genetics Program can be found on the Siteman Cancer Center website at www.siteman.wustl.edu. The Program Director and Genetic Counselors are involved with community education by providing lectures to the community on a variety of topics designed to raise the awareness of cancer genetic issues. Faculty members are also sought for participation in regional tumor board reviews and physician continuing medical education program participation. |
Identify Eligible Clients/Referral |
Patients are referred to the program either by physicians or by self referral. Appointments are scheduled by calling 314.454.6093. Patient referral types include:
|
Pre-test Counseling and Risk Assessment |
Prior to the patient’s first visit, the patient is required to complete a three-generation family history. This information is used to complete the genetic assessment. A genetic counselor is available to assist in the completion of this information. |
Informed Consent Procedures |
Informed consent is obtained for all genetic testing in which the risks and benefits of testing are discussed. The specific type of test to be completed, the cost of the tests, possible test results, and the implications of these results are reviewed with the individual. Written consent is obtained prior to testing. |
Confidentiality Standards |
Privacy is maintained in accordance with institutional guidelines. No patient files are coded. Information obtained on an individual or family is kept within the Hereditary Cancer Clinic records. Any information regarding genetic testing cannot be released without the written consent of the individual. |
||||||||||||||||||||||||||||||||||||||||||
Testing |
Genetic testing is coordinated and sent to in-house and outside institutions that are CAP/CLIA approved. |
||||||||||||||||||||||||||||||||||||||||||
Available Testing at or Through Siteman Cancer Center |
|
||||||||||||||||||||||||||||||||||||||||||
Test Result Interpretation |
A board-certified clinical genetist interprets the results. Risk information is communicated to patient and famly through an out-patient appointment with the genetist and genetic counselor. |
Post-Test Counseling |
Post-test counseling is conducted during an outpatient visit with the genetist and genetic counselor. Counseling includes a thorough review of the test results received and the appropriate follow-up that should be considered based on test results. If testing is recommended among other family members, this is also discussed. Individuals who may be in need of psychological or support services following this process may be referred to the Siteman Cancer Center Psychosocial Service. The discussion that occurred during this visit is prepared in a letter and sent to the individual following the appointment. |
Cancer Screening |
Appropriate follow-up surveillance recommendations are provided during the genetic assessment visit and through a follow-up letter. |
Medical and Surgical Management |
Advice regarding medical and surgical management is dependent on the family cancer history and any lab results. |
Psychological and Supportive Services |
Referrals are provided to appropriate support groups at the Siteman Cancer Center and within the community, as needed. The Siteman Cancer Center has psychologists available for appropriate psychosocial support and counseling. In addition, the center supports a component of a psychiatric consultation service to benefit patients at risk for depression. |
Identifying New Genes |
Washington University School of Medicine was instrumental in the identification of the RET gene responsible for an inherited cancer syndrome called multiple endocrine neolplasia type 2, of MEN2. When mutated, this gene causes tumors in the thyroid gland and other endocrine glands. A successful test for the presence of this gene mutation was established, and now patients at risk for this mutation can benfit from thyroid removal to prevent the occurance of thyroid cancer. Studies of genes that play a role in more commmon cancers are also underway. Research is currently occurring in the following areas:
|
Last updated: 2/20/2008
|
NCCN 1st Annual Forum: Innovative Diagnostics & Therapeutics in Cancer Care™ |
|
|